Stanley C Erck Insider Trading $NVAX NOVAVAX INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Stanley C Erck.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Stanley C Erck. Stanley C Erck is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and CEO and President in NOVAVAX INC ($NVAX) and President and CEO in NOVAVAX INC ($NVAX) and President & CEO in INTERCELL USA, INC. ($IOMI) and President and CEO in INTERCELL USA, INC. ($IOMI).

Stanley C Erck in NOVAVAX INC

Trading Symbol: NVAX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Stanley C Erck: President and CEO, CEO and President
Holdings: 49,606 shares
Current Value: $64,984
Latest Transaction: Dec 16 2020
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Stanley C Erck in NOVAVAX INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BCRX, IOMI, NVAX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 16 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA0.0020,900020,900
Dec 16 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA129.7041,7005,408,49041,700
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseM5.9525,000148,75075,000
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseM5.9525,000148,75075,000
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS109.251,000109,25132,72733.7 K to 32.7 K (-2.96 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS108.401,112120,54433,72734.8 K to 33.7 K (-3.19 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS107.251,000107,24834,83935.8 K to 34.8 K (-2.79 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS106.221,000106,22435,83936.8 K to 35.8 K (-2.71 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS117.0755164,50336,83937.4 K to 36.8 K (-1.47 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS116.08951110,38937,39038.3 K to 37.4 K (-2.48 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS115.231,003115,57738,34139.3 K to 38.3 K (-2.55 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS113.8140145,63939,34339.7 K to 39.3 K (-1.01 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS113.0272782,16839,74440.5 K to 39.7 K (-1.80 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS111.9221624,17540,47140.7 K to 40.5 K (-0.53 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS110.972,343260,01240,68743 K to 40.7 K (-5.45 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS109.988,133894,45843,03051.2 K to 43 K (-15.90 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS109.076,661726,50351,16357.8 K to 51.2 K (-11.52 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS108.203,739404,54957,82461.6 K to 57.8 K (-6.07 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS107.2227629,59361,56361.8 K to 61.6 K (-0.45 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOPayment of ExerciseF111.1811,4291,270,67661,83973.3 K to 61.8 K (-15.60 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOSellD111.181,338148,75973,26874.6 K to 73.3 K (-1.79 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyM5.9525,000148,75074,60649.6 K to 74.6 K (+50.40 %)
Sep 30 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyM5.9525,000148,75049,60624.6 K to 49.6 K (+101.60 %)
Sep 29 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseM0.006,546013,092
Sep 29 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOPayment of ExerciseF113.562,434276,40524,60627 K to 24.6 K (-9.00 %)
Sep 29 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyM0.006,546027,04020.5 K to 27 K (+31.94 %)
Aug 26 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA19.08400,0007,632,000400,000
Jun 29 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA5.95100,000595,000100,000
Jun 29 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA5.95100,000595,000100,000
Mar 10 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseM0.006,07200
Mar 10 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOPayment of ExerciseF12.481,99224,86020,49422.5 K to 20.5 K (-8.86 %)
Mar 10 2020NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyM0.006,072022,48616.4 K to 22.5 K (+36.99 %)
Sep 30 2019NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA0.0019,6380100,000
Sep 30 2019NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA5.95100,000595,000100,000
Sep 30 2019NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA5.95100,000595,000100,000
Sep 30 2019NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA0.0019,6380100,000
Sep 30 2019NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA5.95100,000595,000100,000
Sep 30 2019NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA5.95100,000595,000100,000
Mar 12 2019NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA0.00607,2480607,248
Dec 14 2018NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA2.301,970,0004,531,0001,970,000
May 15 2018NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyP1.65100,000164,620328,279228.3 K to 328.3 K (+43.81 %)
Nov 13 2017NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyP1.13100,000113,050228,279128.3 K to 228.3 K (+77.96 %)
May 11 2017NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyP0.8450,00041,980128,27978.3 K to 128.3 K (+63.87 %)
Nov 16 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA1.35550,000742,500550,000
Nov 16 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA1.35550,000742,500550,000
Apr 01 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseM1.28201,991258,548500,000
Apr 01 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseM1.28198,009253,452701,991
Apr 01 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS5.18226,7691,175,61678,279305 K to 78.3 K (-74.34 %)
Apr 01 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyM1.28201,991258,548305,048103.1 K to 305 K (+196.00 %)
Apr 01 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOSellS5.19198,0091,028,003103,057301.1 K to 103.1 K (-65.77 %)
Apr 01 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOBuyM1.28198,009253,452301,066103.1 K to 301.1 K (+192.14 %)
Mar 17 2016NVAXNOVAVAX INCErck Stanley CPresident and CEOOption ExerciseA4.99900,0004,491,000900,000
Feb 01 2016NVAXNOVAVAX INCErck Stanley CCEO and PresidentBuyP4.382,0729,075103,057101 K to 103.1 K (+2.05 %)
Aug 04 2015NVAXNOVAVAX INCErck Stanley CCEO and PresidentBuyP2.283,2077,312100,98597.8 K to 101 K (+3.28 %)
Mar 09 2015NVAXNOVAVAX INCErck Stanley CCEO and PresidentOption ExerciseA8.94900,0008,046,000900,000

Page:   1

Contact us | Follow us on Twitter